- Home
- RPRX vs GLPI Comparison
RPRX vs GLPI Comparison
Compare RPRX & GLPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- GLPI
- Stock Information
- Founded
- RPRX 1996
- GLPI 2013
- Country
- RPRX United States
- GLPI United States
- Employees
- RPRX N/A
- GLPI N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- GLPI Real Estate Investment Trusts
- Sector
- RPRX Health Care
- GLPI Real Estate
- Exchange
- RPRX Nasdaq
- GLPI Nasdaq
- Market Cap
- RPRX 14.2B
- GLPI 13.1B
- IPO Year
- RPRX 2020
- GLPI N/A
- Fundamental
- Price
- RPRX $31.03
- GLPI $48.53
- Analyst Decision
- RPRX Strong Buy
- GLPI Buy
- Analyst Count
- RPRX 5
- GLPI 18
- Target Price
- RPRX $41.60
- GLPI $53.31
- AVG Volume (30 Days)
- RPRX 4.7M
- GLPI 1.4M
- Earning Date
- RPRX 05-08-2025
- GLPI 04-24-2025
- Dividend Yield
- RPRX 2.77%
- GLPI 6.15%
- EPS Growth
- RPRX N/A
- GLPI 3.52
- EPS
- RPRX 1.91
- GLPI 2.87
- Revenue
- RPRX $2,263,576,000.00
- GLPI $1,531,546,000.00
- Revenue This Year
- RPRX $34.04
- GLPI $6.62
- Revenue Next Year
- RPRX $6.10
- GLPI $3.37
- P/E Ratio
- RPRX $16.63
- GLPI $17.23
- Revenue Growth
- RPRX N/A
- GLPI 6.33
- 52 Week Low
- RPRX $24.05
- GLPI $41.80
- 52 Week High
- RPRX $34.20
- GLPI $52.60
- Technical
- Relative Strength Index (RSI)
- RPRX 36.17
- GLPI 38.45
- Support Level
- RPRX $30.82
- GLPI $50.05
- Resistance Level
- RPRX $31.85
- GLPI $51.44
- Average True Range (ATR)
- RPRX 0.76
- GLPI 0.80
- MACD
- RPRX -0.25
- GLPI -0.22
- Stochastic Oscillator
- RPRX 9.57
- GLPI 4.68
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.